Business Description
Ziccum AB
ISIN : SE0011415595
Compare
Compare
Traded in other countries / regions
ZICC.Sweden7IZ.Germany IPO Date
2020-12-07Description
Ziccum AB develops dry powder preparations of biological pharmaceuticals. It develops and commercializes the patented spray drying technology known as LaminarPace.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.69 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -2.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 9.8 | |||||
| 3-Year EPS without NRI Growth Rate | 9.1 | |||||
| 3-Year FCF Growth Rate | 16.5 | |||||
| 3-Year Book Growth Rate | -45.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.29 | |||||
| 9-Day RSI | 33.22 | |||||
| 14-Day RSI | 37.51 | |||||
| 6-1 Month Momentum % | -5.57 | |||||
| 12-1 Month Momentum % | 2.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.82 | |||||
| Quick Ratio | 1.82 | |||||
| Cash Ratio | 1.29 | |||||
| Days Sales Outstanding | 151.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.9 | |||||
| Shareholder Yield % | -10.85 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -311.74 | |||||
| Net Margin % | -308.92 | |||||
| FCF Margin % | -273.36 | |||||
| ROE % | -125.24 | |||||
| ROA % | -92.67 | |||||
| ROIC % | -174.61 | |||||
| ROC (Joel Greenblatt) % | -271.51 | |||||
| ROCE % | -123.15 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.59 | |||||
| PB Ratio | 6.9 | |||||
| Price-to-Tangible-Book | 6.77 | |||||
| EV-to-EBIT | -3.81 | |||||
| EV-to-EBITDA | -4.06 | |||||
| EV-to-Revenue | 11.89 | |||||
| EV-to-FCF | -4.57 | |||||
| Price-to-Net-Current-Asset-Value | 15.8 | |||||
| Price-to-Net-Cash | 47.4 | |||||
| Earnings Yield (Greenblatt) % | -26.23 | |||||
| FCF Yield % | -20.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ziccum AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.578 | ||
| EPS (TTM) (€) | -0.128 | ||
| Beta | 1.93 | ||
| Volatility % | 81.87 | ||
| 14-Day RSI | 37.51 | ||
| 14-Day ATR (€) | 0.020101 | ||
| 20-Day SMA (€) | 0.5044 | ||
| 12-1 Month Momentum % | 2.85 | ||
| 52-Week Range (€) | 0.42542 - 0.838858 | ||
| Shares Outstanding (Mil) | 15.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ziccum AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ziccum AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ziccum AB Frequently Asked Questions
What is Ziccum AB(FRA:7IZ)'s stock price today?
The current price of FRA:7IZ is €0.47. The 52 week high of FRA:7IZ is €0.84 and 52 week low is €0.43.
When is next earnings date of Ziccum AB(FRA:7IZ)?
The next earnings date of Ziccum AB(FRA:7IZ) is 2024-07-30.
Does Ziccum AB(FRA:7IZ) pay dividends? If so, how much?
Ziccum AB(FRA:7IZ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers